medicinal cannabis
TGA takes action on cannabis ads
Online healthcare platform pays fines of $118,800 over alleged unlawful promotion of medicinal cannabis Healthcare business, Dispended Pty Ltd, has paid six infringement notices issued by the Therapeutic Goods Administration …
Medicinal cannabis: minimising harm in a changing landscape
Regulators have raised the alarm about soaring cannabis scripts, issuing new guidance in a bid to minimise patient harm and curb inappropriate prescribing. Kate Cowling reports on what’s happened—and what …
Alternative healthcare provider directed to cease cannabis ads
TGA orders online healthcare platform to stop advertising medicinal cannabis Healthcare business, Dispended Pty Ltd, has been given 14 days to cease the promotion of medicinal cannabis across a range …
‘Dramatic increase’ in prescription cannabis
Most people are now accessing medical cannabis on script and in safer forms, but “concerning” trend shows many are being prescribed for conditions with no evidence of efficacy Around three-quarters …
Medicinal cannabis: the pharmacist’s role in supporting its rational and safe use by patients
For pharmacists to best support the safe and rational use of medicinal cannabis products, they must be equipped with the relevant knowledge not only about the clinical role of medicinal …
Pharmacy fined over ‘alleged’ cannabis production
Queensland-based pharmacy cops $75,000 fine over alleged “unlawful manufacturing of medicinal cannabis products” The Therapeutic Goods Administration (TGA) has issued four infringement notices to the Caloundra-based Summit Pharmacy Pty Ltd …
Government not in a position to list cannabis on PBS: Butler
Health minister acknowledges cost barriers for patients seeking medicinal cannabis, but says the government has no control over prices suppliers charge Patients prescribed medicinal cannabis are being urged to seek …
Prescriber deficit limiting access to medicinal cannabis
TGA data shows growth in medicinal cannabis approvals, but barriers to access remain Sales of medicinal cannabis products in 2024 are on track to double the number sold in 2023, …
Cannabis workload a factor in non-compliance, owner says
A sudden uptick in medicinal cannabis-related workload, in combination with a bad staff shortage, caused a pharmacy owner to fall behind in his obligations, he says A pharmacist has been …
Medicinal cannabis: risk versus reward
Medicinal cannabis is growing in popularity, promising benefits for a wide variety of conditions. But with most products currently unapproved S8s, pharmacists need to be vigilant. Sheshtyn Paola investigates Medicinal cannabis use is increasing …
Cost of medicinal cannabis has almost halved: Nguyen
Australians share affordability concerns over medicinal cannabis scripts, but leading pharmacist in the space says costs have “dramatically decreased” In a new study of Australians who regularly use drugs led …
Cost, stigma may drive consumers to illicit market
Barriers to medicinal cannabis scripts reported in new Australian study, which suggests need to make scripts pathway “more accessible, affordable and appealing” Australians who report recent use of non-prescribed cannabis …